Allotment of Securities

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 26 October 2026 National Stock Exchange of India Limited BSE Limited NSE Code: SUNPHARMA BSE Code: 524715 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Allotment of Non-Convertible Debentures (NCDs) on private placement basis Further to our earlier communication dated 12 October 2026, we wish to inform you that the Company has today, i.e., 26 October 2026, completed the allotment, on a private placement basis, of rated, listed, unsecured, redeemable, non-convertible debentures (“NCDs”) having an aggregate face value of INR 7,816 crore, comprising:: 1. Series A NCDs having an aggregate face value of INR 2,003 crore; and 2. Series B NCDs having an aggregate face value of INR 5,813 crore. The base issue size of INR 7,000 crore was fully subscribed and, based on the bids received and accepted, the Company exercised the greenshoe option to the extent of ₹816 crore, out of the greenshoe option of up to INR 3,000 crore. The details required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 Annexure A Disclosure under Para (A) of Part (A) of Schedule III to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Particulars Details 1 Type of securities proposed to be Rated, listed, unsecured, redeemable, non- issued (viz. equity shares, convertible debentures (“NCDs” / “Debentures”) convertibles etc.) 2 T ype of issuance Private placement through the electronic book mechanism 3 Total number of securities proposed Series A and Series B Debentures having an to be issued or the total amount for aggregate face value of INR 7,816 crore, allotted as which the securities will be issued follows: 1. Series A Debentures: 2,00,300 Debentures of face value INR 1,00,000 each, issued at par, having an aggregate face value and issue consideration of INR 2,003 crore. 2. Series B Debentures: a. 5,61,300 Debentures of face value INR 1,00,000 each, issued at par, having an aggregate face value and issue consideration of INR 5,613 crore; and b. 20,000 Debentures of face value INR 1,00,000 each, issued at INR 1,00,010 per Debenture, including a premium of INR 10 per Debenture, having an aggregate face value of INR 200 crore and aggregate issue consideration of INR 200.02 crore. 4 Size of the issue accepted The aggregate face value of the NCDs allotted is INR 7,816 crore and the aggregate issue consideration is INR 7,816.02 crore. 5 Whether proposed to be listed? If yes, Yes. The NCDs are proposed to be listed on BSE name of the stock exchange(s) Limited and National Stock Exchange of India Limited. 6 Tenure of the instrument - date of Deemed Date of Allotment: 26 October 2026 allotment and date of maturity Tenor and Scheduled Redemption Date: 1. Series A Debentures: 5 Years and 1 day from the Deemed Date of Allotment, with the Scheduled Redemption Date falling on 27 October 2031, subject to the put option exercisable on 27 March 2028. 2. Series B Debentures: 5 Years and 1 day from the Deemed Date of Allotment, with the Scheduled Redemption Date falling on 27 October 2031. Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 7 Coupon/interest offered, schedule of 1. Series A Debentures – 8.05% p.a. payment of coupon/interest and 2. Series B Debentures – 8.20% p.a. principal Schedule of payment of coupon/interest (Due Date): Series A Debentures* Series B Debentures* 27 March 2027 27 October 2027 27 March 2028 27 October 2028 27 March 2029 27 October 2029 27 March 2030 27 October 2030 27 March 2031 27 October 2031 27 October 2031 *Coupon payments falling on a non-Business Day shall be made in accordance with the applicable Business Day Convention, without affecting subsequent Coupon Payment Dates. Principal: The Debentures shall be redeemed at par on 27 October 2031; Series A Debentures are also redeemable at par pursuant to the put option exercisable on 27 March 2028. 8 Charge/security, if any, created over The Debentures are unsecured and are not secured the Assets by any charge over the assets of the Company. 9 Special right/interest/privileges The holders of the Series A Debentures have a put attached to the instrument and option exercisable on 27 March 2028, subject to the changes thereof terms and notice requirements. 10 Delay in payment of interest / Not Applicable. principal amount for a period of more than three months from the due date or default in payment of interest / principal 11 Details of any letter or comments Not Applicable. regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if any; 12 Details of redemption of Debentures The Debentures are redeemable at par on the Scheduled Redemption Date falling on 27 October 2031. The Series A Debentures are also redeemable pursuant to the put option exercisable on 27 March 2028. Further, the Debentures are subject to mandatory redemption upon the occurrence of specified events, in each case in accordance with the terms of the Key Information Document. 13 Any cancellation or termination of Not Applicable proposal for issuance of securities including reasons thereof Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives